Ona Therapeutics

Oncology

In recognition of Stand Up To Cancer Day, a look at next-generation treatments that are on the verge of making it into clinical practice.

News

Longevity biotech NewLimit's $435m Series C heads this week's round-up of biotech venture capital financings.

Oncology

As ESMO 2026 continues to get underway, pharmaphorum web editor Nicole Raleigh spoke with Scott Clarke, CEO of CatalYm.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.